Speciality Medicines IPO is scheduled to list on 30 Mar 2026 on NSE, BSE.
Listed
SME IPO
SPECIALITYMEDICINES
Speciality Medicines IPO Listing Price Today
Speciality Medicines IPO listed on 30 Mar 2026 at ₹124 against an issue price of ₹124, a listing gain of +0.00%.
- Issue price
- ₹124
- Actual listing price
- ₹124
- Listing Date
- 30 Mar 2026
- Exchange
- NSE, BSE
Live share price
Speciality Medicines share price
-
vs issue price
Open-
Day high-
Day low-
Exchange-
Loading live price…
The live price isn't available right now. Check back shortly.
Source: Yahoo Finance. Prices may be delayed by a few minutes.
GMP vs actual
Speciality Medicines expected listing price
| Issue price | ₹124 |
|---|---|
| Latest GMP | TBA |
| Expected listing price (issue price + GMP) | TBA |
| Actual listing price | ₹124 |
| Listing gain | +0.00% |
Profit per application
₹0
At the listing price, for 2,000 shares
GMP is an unofficial grey market indicator, not a guarantee of the listing price.
Empirical GMP Accuracy:
Across 117 Indian IPOs, positive GMP predicted positive listing gains 69.8% of the time (35.6% of SME IPOs opened within 10% of their GMP estimate).
View Research Report →
GMP trend
Speciality Medicines GMP trend before listing
| Date | GMP | Change |
|---|---|---|
| 26 Mar 2026 | ₹0.00 | - |
| 24 Mar 2026 | ₹0.00 | - |
| 23 Mar 2026 | ₹0.00 | - |
| 18 Mar 2026 | ₹0.00 | - |
Listing day
Listing day timings
| Listing Date | 30 Mar 2026 |
|---|---|
| Special pre-open session | 9:00 AM - 9:45 AM |
| Normal trading starts | 10:00 AM |
| Exchange | NSE, BSE |
FAQ
Speciality Medicines IPO: frequently asked questions
Speciality Medicines IPO listed at ₹124 against an issue price of ₹124, a listing gain of +0.00%.
On listing day, a special pre-open session runs from 9:00 AM to 9:45 AM to set the listing price. Speciality Medicines shares then start normal trading at 10:00 AM.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
At the listing price, one minimum application of 2,000 shares in Speciality Medicines IPO made about ₹0.